Confounding

5,884views

Confounding

Watch later

Watch later

Human herpesvirus 8 (Kaposi sarcoma)
Herpes simplex virus
Human herpesvirus 6 (Roseola)
Adenovirus
Parvovirus B19
Human papillomavirus
BK virus (Hemorrhagic cystitis)
JC virus (Progressive multifocal leukoencephalopathy)
Poliovirus
Coxsackievirus
Rhinovirus
Hepatitis A and Hepatitis E virus
Influenza virus
Mumps virus
Measles virus
Respiratory syncytial virus
Human parainfluenza viruses
Yellow fever virus
Zika virus
Hepatitis C virus
West Nile virus
Norovirus
Rotavirus
HIV (AIDS)
Rabies virus
Rubella virus
Prions (Spongiform encephalopathy)
Candida
Plasmodium species (Malaria)
Trypanosoma cruzi (Chagas disease)
Protein synthesis inhibitors: Aminoglycosides
Antimetabolites: Sulfonamides and trimethoprim
Antituberculosis medications
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Cell wall synthesis inhibitors: Penicillins
Miscellaneous protein synthesis inhibitors
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Mechanisms of antibiotic resistance
Integrase and entry inhibitors
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Hepatitis medications
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Neuraminidase inhibitors
Herpesvirus medications
Azoles
Echinocandins
Miscellaneous antifungal medications
Anthelmintic medications
Antimalarials
Anti-mite and louse medications
Nuclear structure
DNA structure
Transcription of DNA
Translation of mRNA
Gene regulation
Epigenetics
Amino acids and protein folding
Nucleotide metabolism
DNA replication
Lac operon
DNA damage and repair
Cell cycle
Mitosis and meiosis
DNA mutations
Lesch-Nyhan syndrome
Adenosine deaminase deficiency
Purine and pyrimidine synthesis and metabolism disorders: Pathology review
Polymerase chain reaction (PCR) and reverse-transcriptase PCR (RT-PCR)
Gel electrophoresis and genetic testing
ELISA (Enzyme-linked immunosorbent assay)
Karyotyping
DNA cloning
Fluorescence in situ hybridization
Mendelian genetics and punnett squares
Hardy-Weinberg equilibrium
Inheritance patterns
Independent assortment of genes and linkage
Evolution and natural selection
Down syndrome (Trisomy 21)
Edwards syndrome (Trisomy 18)
Patau syndrome (Trisomy 13)
Fragile X syndrome
Huntington disease
Myotonic dystrophy
Friedreich ataxia
Turner syndrome
Klinefelter syndrome
Prader-Willi syndrome
Angelman syndrome
Cri du chat syndrome
Williams syndrome
Alagille syndrome (NORD)
Achondroplasia
Polycystic kidney disease
Familial adenomatous polyposis
Familial hypercholesterolemia
Marfan syndrome
Multiple endocrine neoplasia
Neurofibromatosis
Tuberous sclerosis
von Hippel-Lindau disease
Albinism
Cystic fibrosis
Gaucher disease (NORD)
Glycogen storage disease type I
Glycogen storage disease type II (NORD)
Hemochromatosis
Mucopolysaccharide storage disease type 1 (Hurler syndrome) (NORD)
Leukodystrophy
Niemann-Pick disease types A and B (NORD)
Niemann-Pick disease type C
Phenylketonuria (NORD)
Sickle cell disease (NORD)
Tay-Sachs disease (NORD)
Alpha-thalassemia
Beta-thalassemia
Wilson disease
Alport syndrome
X-linked agammaglobulinemia
Fabry disease (NORD)
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Hemophilia
Mucopolysaccharide storage disease type 2 (Hunter syndrome) (NORD)
Muscular dystrophy
Wiskott-Aldrich syndrome
Mitochondrial myopathy
Autosomal trisomies: Pathology review
Muscular dystrophies and mitochondrial myopathies: Pathology review
Miscellaneous genetic disorders: Pathology review
Human development days 1-4
Human development days 4-7
Human development week 2
Human development week 3
Ectoderm
Mesoderm
Endoderm
Development of the placenta
Development of the fetal membranes
Development of twins
Hedgehog signaling pathway
Development of the digestive system and body cavities
Development of the umbilical cord
Development of the cardiovascular system
Fetal circulation
Development of the face and palate
Pharyngeal arches, pouches, and clefts
Development of the gastrointestinal system
Development of the teeth
Development of the tongue
Development of the axial skeleton
Development of the muscular system
Development of the renal system
Development of the reproductive system
Development of the respiratory system
Cellular structure and function
Cell membrane
Selective permeability of the cell membrane
Extracellular matrix
Cell-cell junctions
Endocytosis and exocytosis
Osmosis
Resting membrane potential
Nernst equation
Cytoskeleton and intracellular motility
Cell signaling pathways
Adrenoleukodystrophy (NORD)
Zellweger spectrum disorders (NORD)
Ehlers-Danlos syndrome
Peroxisomal disorders: Pathology review
Introduction to biostatistics
Types of data
Probability
Mean, median, and mode
Range, variance, and standard deviation
Standard error of the mean (Central limit theorem)
Normal distribution and z-scores
Paired t-test
Two-sample t-test
Hypothesis testing: One-tailed and two-tailed tests
One-way ANOVA
Two-way ANOVA
Repeated measures ANOVA
Correlation
Methods of regression analysis
Linear regression
Logistic regression
Type I and type II errors
Sensitivity and specificity
Positive and negative predictive value
Test precision and accuracy
Incidence and prevalence
Relative and absolute risk
Odds ratio
Mortality rates and case-fatality
DALY and QALY
Direct standardization
Indirect standardization
Study designs
Ecologic study
Cross sectional study
Case-control study
Cohort study
Randomized control trial
Clinical trials
Sample size
Disease causality
Selection bias
Information bias
Confounding
Interaction
Prevention
Major depressive disorder
Suicide
Bipolar and related disorders
Major depressive disorder with seasonal pattern
Generalized anxiety disorder
Social anxiety disorder
Panic disorder
Phobias
Obsessive-compulsive disorder
Body focused repetitive disorders
Post-traumatic stress disorder
Schizophrenia
Delirium
Amnesia
Dissociative disorders
Anorexia nervosa
Bulimia nervosa
Cluster A personality disorders
Cluster B personality disorders
Cluster C personality disorders
Somatic symptom disorder
Factitious disorder
Tobacco use disorder
Opioid use disorder
Cannabis use disorder
Cocaine use disorder
Alcohol use disorder
Bruxism
Insomnia
Narcolepsy (NORD)
Erectile dysfunction
Attention deficit hyperactivity disorder
Disruptive, impulse control, and conduct disorders
Learning disability
Fetal alcohol syndrome
Tourette syndrome
Autism spectrum disorder
Rett syndrome
Mood disorders: Pathology review
Amnesia, dissociative disorders and delirium: Pathology review
Personality disorders: Pathology review
Eating disorders: Pathology review
Psychological sleep disorders: Pathology review
Psychiatric emergencies: Pathology review
Drug misuse, intoxication and withdrawal: Hallucinogens: Pathology review
Malingering, factitious disorders and somatoform disorders: Pathology review
Trauma- and stress-related disorders: Pathology review
Selective serotonin reuptake inhibitors
Serotonin and norepinephrine reuptake inhibitors
Tricyclic antidepressants
Monoamine oxidase inhibitors
Atypical antidepressants
Typical antipsychotics
Atypical antipsychotics
Lithium
Nonbenzodiazepine anticonvulsants
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Psychomotor stimulants

Transcript

Watch video only

A confounder is a variable in a study that distorts the true relationship between an exposure and an outcome, so it looks like the exposure and the outcome are either more associated or less associated than they really are.

For example, let’s say you hear on the news that drinking coffee is associated with developing heart disease, and - because you drink a lot of coffee - you decide to conduct a study to see if this is true.

First, you recruit 100 people that drink coffee and 100 people that don’t drink coffee, follow them for ten years, and then compare the number of people who developed heart disease in each group.

First, off you must really love coffee and be fairly wealthy to spend ten years studying it at the drop of a hat.

Now, let’s say that the proportion of people who develop heart disease in the coffee drinking group is - 50 out of 100, or 50% - and proportion of people who develop heart disease in the non-coffee drinking group - is 20 out of 100, or 20%.

Comparing 50% and 20%, you get a relative risk of 2.5, meaning the risk of developing heart disease for people that drink coffee is 2.5 times the risk for people that don’t drink coffee.

The association between coffee drinking and heart disease can be represented by an arrow pointing from the exposure to the outcome.

The arrow represents a potential causal relationship - in other words, coffee drinking potentially causes the development of heart disease.

But does drinking coffee really cause heart disease? Maybe, or maybe there’s a mysterious third variable - like smoking - that’s confounding the relationship, or making it look like there’s an association when there really isn’t one.

To be considered a confounder, two conditions have to be met.

The first condition is that a variable has to be associated with the exposure - meaning that the variable is seen to occur significantly more frequently among one group than the other.

So in this case, people that smoke would have to be either more or less likely to drink coffee compared to people that don’t smoke.

For example, 45 people - or 45% - in the coffee drinking group smoked compared to 5 people - or 5% - in the non-coffee drinking group, so people that smoked are 9 times more likely to drink coffee than people that don’t smoke.

Let’s suppose that smoking cigarettes makes people crave coffee, so 90% of people who smoke also drink coffee, while only 50% of people who don’t smoke also drink coffee.

This relationship can be represented by an arrow pointing from smoking to coffee drinking, since people that smoke are more likely to drink coffee than people who don’t smoke.

The second condition is that a confounder has to be associated with the outcome, so smoking would have to be associated with developing heart disease.

In our study, of the 50 people that smoked, 40 people - 80% - developed heart disease, and 10 people - 20% - didn’t develop heart disease.

So the risk of heart disease for people that smoke is 4 times higher compared to people that don’t smoke.

Since smoking damages the lining of blood vessels, it’s makes sense that people who smoke are more likely to develop heart disease than people that don’t smoke.

This relationship can be represented by drawing an arrow from smoking to heart disease, since an increase in smoking leads to an increase in heart disease.

So, looking at the diagram, we can see that an increase in smoking leads to an increase in coffee drinking and an increase in heart disease.

So even though it looks like there’s a relationship between the two variables, it’s hard to know whether or not heart disease is dependent on coffee, since the risk of heart disease also depends on whether or not a person smokes cigarettes.

In some cases, the mysterious third variable has a different relationship with the exposure - specifically that it’s caused by the exposure.

In that case, the variable may be considered a mediator.

For example, let’s say that we wanted to look at the relationship between obesity and heart disease, and let’s say that cholesterol levels are the third variable.

An increase in obesity is typically associated with an increase in cholesterol, and an increase in cholesterol is typically associated with an increased risk of heart disease.

The reason cholesterol isn’t a confounder in this situation is because simply increasing a person’s cholesterol doesn’t necessarily change a person’s weight, so cholesterol has no influence on obesity.

So, here, we could essentially take cholesterol out of the diagram and we’ll still see the true association between obesity and heart disease.

Confounding generally occurs when the two groups being compared aren’t similar to one another - like if there are more smokers in one group than the other.

There are three methods you can use when designing your study to make sure that the two study groups are similar: randomization, restriction of the study population and matching.

Randomized controlled trials use a tool called randomization, meaning individuals get selected to each study group through a process of chance.

Using randomization, there’s a pretty high chance that each group will have similar characteristics.

Key Takeaways

A confounding variable is a variable that distorts the accurate relationship between exposure and the outcome. For example, suppose you're studying the effects of a new drug. In that case, age might be a confounding variable because the drug may affect people of different ages differently. Confounders can make the outcome and exposure look more or less than they are.

There are many ways to control for confounding variables, such as stratifying your data (i.e., dividing your data into subgroups) or using multivariate analysis. However, there is no perfect way to completely eliminate confounding variables, so always be aware of them and try to account for them as best you can.